Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Ronald L. Magolda"'
Autor:
Shen Z, Tom A. Comery, David Smith, Brian J. Platt, Terrance H. Andree, Zhang Minsheng, Magid Abou-Gharbia, Sukoff-Rizzo Sj, Havran Lm, Chong Dc, Natasha Kagan, Zoë A. Hughes, Kelly Sullivan, Bach Ac rd, Boyd L. Harrison, Wayne E. Childers, Magda Asselin, Sharon Rosenzweig-Lipson, Claudine Pulicicchio, Steven M. Grauer, Marathias, George Theodore Grosu, Mark Day, Bicksler Jj, Chad E. Beyer, Adedayo Adedoyin, Christine Huselton, Sabb Al, Suzan Aschmies, Ronald L. Magolda, Warren D. Hirst, Kleintop T, Albert J. Robichaud
Publikováno v:
Journal of Medicinal Chemistry. 53:4066-4084
As part of an effort to identify 5-HT(1A) antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound 10a was identified from earlier work in a combined 5-HT(1A) antagonist/SSRI program. T
Autor:
Diane B. Hauze, Michael C. Sharp, Bheem M. Bhat, Paula Green, Colleen Milligan, Daniel M. Green, Jennifer Pirrello, Peter V.N. Bodine, Ronald L. Magolda, Adam M. Gilbert, Matthew D. Vera, Yogendra P. Kharode, Valerie E. Coleburn, Luciana De Araujo Felix, Mattew G. Bursavich, Nipa Alon, Jeanne J. Matteo, Jay Wrobel, Frederick J. Bex, Jeffrey C. Pelletier, Susan Lockhead, Joseph T. Lundquist, Richard J. Murrills, Ray Unwalla, Paul J. Yaworsky, Sally Selim, John F. Mehlmann, Ho-Sun Lam
Publikováno v:
Journal of Medicinal Chemistry. 52:6962-6965
A high-throughput screening campaign to discover small molecule leads for the treatment of bone disorders concluded with the discovery of a compound with a 2-aminopyrimidine template that targeted the Wnt beta-catenin cellular messaging system. Hit-t
Autor:
William R. Adams, Irene Feingold, John F. Mehlmann, Cesario O Tio, Joshua E. Cottom, Jay E. Wrobel, Jeffrey C. Pelletier, Daniel M. Green, John F. Rogers, James W. Jetter, Murty Chengalvala, Joseph T. Lundquist, Charles William Mann, Linda Shanno, Ronald L. Magolda, Diane B. Hauze, Gregory S. Kopf, Christine Huselton
Publikováno v:
Journal of Medicinal Chemistry. 52:2148-2152
A potent, highly insoluble, GnRH antagonist with a 2-phenyl-4-piperazinylbenzimidazole template and a quinoxaline-2,3-dione pharmacophore was modified to maintain GnRH antagonist activity and improve in vitro pharmaceutical properties. Structural cha
Autor:
Michael P. Winters, Renee L. DesJarlais, Mark Bobko, John P. Wolak, Ho Yin Lo, Steven S. Pullen, Deborah D. Jeanfavre, Hnin Hnin Khine, Rosemarie H. Sallati, Ernest L. Raymond, Mohammed A. Kashem, Lei Qiao, Gregory P. Roth, Declan Ryan, Joseph R. Woska, Kevin J. Moriarty, Darius Robinson, Hidenori Takahashi, B. Tomczuk, Wilson Matthew Allan, Ronald L. Magolda, Peter Allen Nemoto, Andre White, Brian Nicholas Cook
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:5545-5549
A series of novel potent benzimidazole based inhibitors of interleukin-2 T-cell kinase (Itk) were prepared. In this report, we discuss the structure-activity relationship (SAR), selectivity, and cell-based activity for the series. We also discuss the
Autor:
Andrew R. Wood, Guy T. Carter, Edmund I. Graziani, Menelas N. Pangalos, Kevin Pong, Frank E. Koehn, Benfang Ruan, Ronald L. Magolda, Magid Abou-Gharbia, Robert A. Crozier, Flora Jow, Frann Bennett, Danni Liu, Mark R. Bowlby, Peter H. Reinhart, Xidong Feng, Mary Lynn T. Mercado, Leonard A. McDonald, Shi Liang, Yi Chen, Jerauld S. Skotnicki, Margaret M. Zaleska, David von Schack
Publikováno v:
Proceedings of the National Academy of Sciences. 105:33-38
Rapamycin is an immunosuppressive immunophilin ligand reported as having neurotrophic activity. We show that modification of rapamycin at the mammalian target of rapamycin (mTOR) binding region yields immunophilin ligands, WYE-592 and ILS-920, with p
Autor:
Ronald C. Bernotas, David Zenan Li, Hassan Mahmoud Elokdah, Lee E. Schechter, Geraldine Ruth Mcfarlane, Guo Ming Zhang, Deborah L. Smith, Albert J. Robichaud, Ronald L. Magolda
Publikováno v:
Bioorganic & Medicinal Chemistry. 15:6208-6226
1-Aminoethyl-3-arylsulfonyl-1H-indoles 1 are 5-HT(6) receptor ligands with modest activity in a 5-HT(6) cyclase assay. Introduction of an additional nitrogen in the indole ring provides 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines 2 with bo
Autor:
Kathy O’Shea, Denice M. Spero, Ronald L. Magolda, Mario G. Cardozo, Lisa H. Liu, Hanbo Hu, Derek Cogan, Heather Grbic, Thomas M. Farrell, John P. Wolak, John D. Ginn, Della White, Deborah D. Jeanfavre, Mohammed A. Kashem, Maryanne L. Brown, Anthony S. Prokopowicz, Carol Ann Homon, Erick R. R. Young, Joseph R. Woska, Paul Kaplita, Darren Disalvo, Georg Dahmann, Charles L. Cywin
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:225-230
An uHTS campaign was performed to identify selective inhibitors of PKC-theta. Initial triaging of the hit set based on selectivity and historical analysis led to the identification of 2,4-diamino-5-nitropyrimidines as potent and selective PKC-theta i
Autor:
Joseph J. Petraitis, Margaret F. Favata, Joseph B. Santella, Robert A. Copeland, John Wityak, Ronald L. Magolda, James M. Trzaskos, Bruce D. Jaffe, George L. Trainor, Gardner Daniel S, Peggy A. Scherle, Kurumi Y. Horiuchi, Jung-Hui Sun, Frank W. Hobbs, Andrea J. Daulerio, John V. Duncia
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 14:1483-1486
Employing phenylmalonitrile dianion chemistry, a large number of analogues of MEK inhibitor lead SH053 (IC(50)=140 nM) were rapidly synthesized leading to single digit nM inhibitors, displaying submicromolar AP-1 transcription inhibition in COS-7 cel
Autor:
Chu-Biao Xue, Xiaohua He, John Roderick, Ronald L Corbett, James J.-W Duan, Rui-Qin Liu, Maryanne B Covington, Mingxin Qian, Maria D Ribadeneira, Krishna Vaddi, David D Christ, Robert C Newton, James M Trzaskos, Ronald L Magolda, Ruth R Wexler, Carl P Decicco
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:4299-4304
Modifications of the lead TACE inhibitor 1 (N-hydroxy-trans-2-{[4-(4-quinolinyloxymethyl)anilinyl]carbonyl}-1-cyclohexanecarboxamide) at the cyclohexyl ring and the quinoline moiety led to the identification of a series of piperidine containing TACE
Autor:
James M. Trzaskos, Carl P. Decicco, Jingwu Duan, Chu-Biao Xue, Robert C. Newton, Rui-Qin Liu, Zelda R. Wasserman, Jennifer L. Seng, Zhonghui Lu, Ronald L. Magolda, Xiaohua He, John Roderick, Maryanne B. Covington
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:2035-2040
New inhibitors of tumor necrosis factor-α converting enzyme (TACE) were discovered using an N -hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamide scaffold. The series was found to be potent in a porcine TACE (pTACE) assay with IC 50 s typically below 5 nM. F